Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology

Volumn 70, Issue 19 PART 1, 2008, Pages 1707-1714

  Naumann, M ^a   So, Y ^b   Argoff, C E ^d   Childers, M K ^e   Dykstra, D D ^f   Gronseth, G S ^g   Jabbari, B ^h   Kaufmann, H C ^c   Schurch, B ⁱ   Silberstein, S D ^j   Simpson, D M ^k  

^a KLINIKUM AUGSBURG   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c Department of Neurology ^*  (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF KANSAS   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^j THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; RESINIFERATOXIN; SODIUM CHLORIDE;

ARM WEAKNESS; ARTICLE; AUTONOMIC NEUROPATHY; AXILLARY HYPERHIDROSIS; CHRONIC DAILY HEADACHE; CHRONIC PAIN; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DIPLOPIA; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; FLU LIKE SYNDROME; HEADACHE; HUMAN; HYPERSALIVATION; INJECTION PAIN; INJECTION SITE CONTUSION; INJECTION SITE PAIN; LOW BACK PAIN; LOW DRUG DOSE; MIGRAINE; MUSCLE WEAKNESS; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PALMAR HYPERHIDROSIS; PRIORITY JOURNAL; PTOSIS; SIDE EFFECT; SKIN TENSION; SPINAL CORD INJURY; SWEAT GLAND DISEASE; TRANSFORMED MIGRAINE; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; URINE RETENTION; XEROSTOMIA;

EID: 43149084857     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000311390.87642.d8     Document Type: Article

References (34)

1. DM Simpson J-M Gracies HK Graham Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 2008 1707 1714
2. DM Simpson A Blitzer A Brashear Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 2008 1691 1698
3. M Naumann NJ Lowe Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial BMJ 323 2001 596 599
4. M Heckmann AO Ceballos-Baumann G Plewig Botulinum toxin A for axillary hyperhidrosis (excessive sweating) N Engl J Med 344 2001 488 493
5. NJ Lowe PS Yamauchi GP Lask R Patnaik S Iyer Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study Dermatol Surg 28 2002 822 827
6. P Schnider M Binder E Auff H Kittler T Berger K Wolff Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms Br J Dermatol 136 1997 548 552
7. D Saadia A Voustianiouk AK Wang H Kaufmann Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study Neurology 57 2001 2095 2099
8. M Naumann M Zellner KV Toyka K Reiners Treatment of gustatory sweating with botulinum toxin Ann Neurol 42 1997 973 975
9. A Eckardt C Kuettner Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A Head Neck 25 2003 624 628
10. O Laccourreye E Akl R Gutierrez-Fonseca D Garcia D Brasnu B Bonan Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome Arch Otolaryngol Head Neck Surg 125 1999 283 286
11. F Mancini R Zangaglia S Cristina Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism Mov Disord 18 2003 685 688
12. WG Ondo C Hunter W Moore A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease Neurology 62 2004 37 40
13. A Lipp T Trottenberg T Schink A Kupsch G Arnold A randomized trial of botulinum toxin A for treatment of drooling Neurology 61 2003 1279 1281
14. G Lagalla M Millevolte M Capecci L Provinciali MG Ceravolo Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study Mov Disord 21 2006 704 707
15. B Boroojerdi A Ferbert M Schwarz H Herath J Noth Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy J Neurol Neurosurg Psychiatry 65 1998 111 114
16. P Gallien JM Reymann G Amarenco B Nicolas M de Seze E Bellissant Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients J Neurol Neurosurg Psychiatry 76 2005 1670 1676
17. DD Dykstra AA Sidi Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study Arch Phys Med Rehabil 71 1990 24 26
18. M de Seze H Petit P Gallien Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease Eur Urol 42 2002 56 62
19. B Schurch M de Seze P Denys Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study J Urol 174 2005 196 200
20. M Ghei BH Maraj R Miller Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial J Urol 174 2005 1873 1877 discussion 1877
21. A Giannantoni SM Di Stasi RL Stephen V Bini E Costantini M Porena Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study J Urol 172 2004 240 243
22. L Foster L Clapp M Erickson B Jabbari Botulinum toxin A and chronic low back pain: a randomized, double-blind study Neurology 56 2001 1290 1293
23. AH Elkind P O’Carroll A Blumenfeld R DeGryse R Dimitrova A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis J Pain 7 2006 688 696
24. Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine. Pain 2008 (in press).
25. S Evers J Vollmer-Haase S Schwaag A Rahmann IW Husstedt A Frese Botulinum toxin A in the prophylactic treatment of migraine: a randomized, double-blind, placebo-controlled study Cephalalgia 24 2004 838 843
26. WJ Schulte-Mattler P Krack Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study Pain 109 2004 110 114
27. S Silberstein N Mathew J Saper S Jenkins Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group [comment] Headache 40 2000 445 450
28. WG Ondo KD Vuong HS Derman Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study Cephalalgia 24 2004 60 65
29. NT Mathew BM Frishberg M Gawel R Dimitrova J Gibson C Turkel Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial Headache 45 2005 293 307
30. DW Dodick A Mauskop AH Elkind R DeGryse MF Brin SD Silberstein Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Headache 45 2005 315 324
31. SD Silberstein SR Stark SM Lucas SN Christie RE Degryse CC Turkel Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial Mayo Clin Proc 80 2005 1126 1137
32. M Padberg SF de Bruijn RJ de Haan DL Tavy Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial Cephalalgia 24 2004 675 680
33. M Relja S Telarovic Botulinum toxin in tension-type headache J Neurol 251 suppl 1 2004 I12 I14
34. SD Silberstein H Gobel R Jensen Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study [see comment] Cephalalgia 26 2006 790 800